Clinical trial: An open-label, randomised trial of different re-start strategies after treatment withdrawal in HBeAg negative chronic hepatitis B : Alimentary Pharmacology & Therapeutics

Asgeir Johannessen1,2,3 | Dag Henrik Reikvam2,3 | Soo Aleman 4 | Nega Berhe1,2,5 | Nina Weis 6,7 | Hailemichael Desalegn1,2024-09-032024-09-032024-09-03http://98.70.32.231:4000/handle/123456789/1349Clinical trial: An open-label, randomised trial of different re-start strategies after treatment withdrawal in HBeAg negative chronic hepatitis B : Alimentary Pharmacology & TherapeuticsArticle